Latest Insider Transactions at Adaptive Biotechnologies Corp (ADPT)
This section provides a real-time view of insider transactions for Adaptive Biotechnologies Corp (ADPT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Adaptive Biotechnologies Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Adaptive Biotechnologies Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2020
|
Julie Rubinstein President and COO |
SELL
Open market or private sale
|
Direct |
15,000
-73.46%
|
$900,000
$60.51 P/Share
|
|
Dec 29
2020
|
Julie Rubinstein President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Dec 29
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
16,790
-0.31%
|
$990,610
$59.67 P/Share
|
|
Dec 29
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
16,790
+0.93%
|
$0
$0.33 P/Share
|
|
Dec 28
2020
|
Julie Rubinstein President and COO |
SELL
Open market or private sale
|
Direct |
15,000
-77.72%
|
$930,000
$62.55 P/Share
|
|
Dec 28
2020
|
Julie Rubinstein President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Dec 28
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
16,250
-0.23%
|
$1,007,500
$62.05 P/Share
|
|
Dec 28
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
16,250
+0.9%
|
$0
$0.33 P/Share
|
|
Dec 24
2020
|
Julie Rubinstein President and COO |
SELL
Open market or private sale
|
Direct |
15,000
-69.57%
|
$945,000
$63.89 P/Share
|
|
Dec 24
2020
|
Julie Rubinstein President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Dec 23
2020
|
Julie Rubinstein President and COO |
SELL
Open market or private sale
|
Direct |
15,000
-80.23%
|
$960,000
$64.63 P/Share
|
|
Dec 23
2020
|
Julie Rubinstein President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Dec 22
2020
|
Nancy Louise Hill EVP, Operations & Program Mana |
SELL
Open market or private sale
|
Direct |
57,000
-60.85%
|
$3,591,000
$63.79 P/Share
|
|
Dec 22
2020
|
Nancy Louise Hill EVP, Operations & Program Mana |
BUY
Exercise of conversion of derivative security
|
Direct |
57,000
+45.97%
|
$0
$0.84 P/Share
|
|
Dec 22
2020
|
Julie Rubinstein President and COO |
SELL
Open market or private sale
|
Direct |
15,000
-93.67%
|
$945,000
$63.99 P/Share
|
|
Dec 22
2020
|
Julie Rubinstein President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Dec 21
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
417
-100.0%
|
$24,603
$59.14 P/Share
|
|
Dec 21
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
BUY
Exercise of conversion of derivative security
|
Direct |
417
+50.0%
|
$2,502
$6.27 P/Share
|
|
Dec 21
2020
|
Michael J Pellini Director |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$1,500,000
$60.0 P/Share
|
|
Dec 21
2020
|
Michael J Pellini Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$150,000
$6.55 P/Share
|
|
Dec 21
2020
|
Julie Rubinstein President and COO |
SELL
Open market or private sale
|
Direct |
15,000
-75.59%
|
$885,000
$59.44 P/Share
|
|
Dec 21
2020
|
Julie Rubinstein President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.32 P/Share
|
|
Dec 15
2020
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,000
-93.98%
|
$112,000
$56.4 P/Share
|
|
Dec 15
2020
|
Francis Lo Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$14,000
$7.8 P/Share
|
|
Dec 15
2020
|
Robert Hershberg Director |
SELL
Open market or private sale
|
Direct |
2,000
-93.98%
|
$112,000
$56.39 P/Share
|
|
Dec 15
2020
|
Robert Hershberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$0
$0.45 P/Share
|
|
Dec 14
2020
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
6,000
-61.16%
|
$348,000
$58.61 P/Share
|
|
Dec 14
2020
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+50.0%
|
$42,000
$7.8 P/Share
|
|
Dec 14
2020
|
Nancy Louise Hill EVP, Operations & Program Mana |
SELL
Open market or private sale
|
Direct |
40,000
-80.0%
|
$2,360,000
$59.0 P/Share
|
|
Dec 14
2020
|
Nancy Louise Hill EVP, Operations & Program Mana |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+44.44%
|
$0
$0.84 P/Share
|
|
Dec 14
2020
|
Viking Global Investors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,000
-3.23%
|
$55,000,000
$55.65 P/Share
|
|
Dec 11
2020
|
Charles Sang SVP, External Affairs |
SELL
Open market or private sale
|
Direct |
50,000
-100.0%
|
$2,800,000
$56.13 P/Share
|
|
Dec 11
2020
|
Charles Sang SVP, External Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
$300,000
$6.55 P/Share
|
|
Dec 10
2020
|
Susan Bobulsky Chief Commercial Officer, MRD |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$1,375,000
$55.0 P/Share
|
|
Dec 10
2020
|
Susan Bobulsky Chief Commercial Officer, MRD |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$25,000
$1.98 P/Share
|
|
Dec 08
2020
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-58.77%
|
$1,530,000
$51.75 P/Share
|
|
Dec 08
2020
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+49.18%
|
$180,000
$6.32 P/Share
|
|
Dec 07
2020
|
Lance Baldo Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,250
-55.77%
|
$312,500
$50.06 P/Share
|
|
Dec 07
2020
|
Lance Baldo Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+50.0%
|
$43,750
$7.8 P/Share
|
|
Dec 01
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
6,770
-72.73%
|
$324,960
$48.82 P/Share
|
|
Dec 01
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
BUY
Exercise of conversion of derivative security
|
Direct |
6,770
+34.03%
|
$40,620
$6.79 P/Share
|
|
Nov 23
2020
|
Stacy L Taylor SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
2,880
-34.64%
|
$132,480
$46.0 P/Share
|
|
Nov 23
2020
|
Stacy L Taylor SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,880
+30.64%
|
$20,160
$7.18 P/Share
|
|
Nov 19
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
416
-100.0%
|
$19,968
$48.86 P/Share
|
|
Nov 19
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
BUY
Exercise of conversion of derivative security
|
Direct |
416
+50.0%
|
$2,496
$6.27 P/Share
|
|
Nov 19
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
16,680
-0.23%
|
$783,960
$47.15 P/Share
|
|
Nov 19
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
16,680
+0.92%
|
$0
$0.33 P/Share
|
|
Nov 18
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
16,680
-0.31%
|
$783,960
$47.61 P/Share
|
|
Nov 18
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
16,680
+0.92%
|
$0
$0.33 P/Share
|
|
Nov 17
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
16,680
-0.47%
|
$767,280
$46.26 P/Share
|